* Vivos Therapeutics press release [https://seekingalpha.com/pr/20205846-vivos-therapeutics-reports-second-quarter-2025-financial-results-and-provides-operational] (NASDAQ:VVOS [https://seekingalpha.com/symbol/VVOS]): Q2 GAAP EPS of -$0.55.
* Revenue of $3.82M (-5.7% Y/Y).
MORE ON VIVOS THERAPEUTICS
* Seeking Alpha’s Quant Rating on Vivos Therapeutics [https://seekingalpha.com/symbol/VVOS/ratings/quant-ratings]
* Historical earnings data for Vivos Therapeutics [https://seekingalpha.com/symbol/VVOS/earnings]
* Financial information for Vivos Therapeutics [https://seekingalpha.com/symbol/VVOS/income-statement]
Vivos Therapeutics GAAP EPS of -$0.55, revenue of $3.82M
Published 2 months ago
Aug 20, 2025 at 9:59 AM
Neutral
Auto